Literature DB >> 28584150

Upregulation of Apoptosis Pathway Genes in Peripheral Blood Mononuclear Cells of HIV-Infected Individuals with Antiretroviral Therapy-Associated Mitochondrial Toxicity.

Yram Foli1, Musie Ghebremichael2, Min Li1, Elijah Paintsil3,2,4,5.   

Abstract

A case-control study of the effect of antiretroviral therapy (ART) on apoptosis pathway genes comprising 16 cases (HIV infected with mitochondrial toxicity) and 16 controls (HIV uninfected) was conducted. A total of 26 of 84 genes of the apoptosis pathway were differentially expressed. Two of the upregulated genes, DFFA and TNFRSF1A, classified 75% of study participants correctly as either a case or control. Thus, apoptosis may be in the causal pathway of ART-associated mitochondrial toxicity. These two genes could be markers for detecting and monitoring ART-induced mitochondrial toxicity.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  antiretroviral therapy; apoptosis; biomarker; mitochondrial toxicity

Mesh:

Substances:

Year:  2017        PMID: 28584150      PMCID: PMC5527626          DOI: 10.1128/AAC.00522-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

1.  HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism.

Authors:  D Genini; D Sheeter; S Rought; J J Zaunders; S A Susin; G Kroemer; D D Richman; D A Carson; J Corbeil; L M Leoni
Journal:  FASEB J       Date:  2000-11-09       Impact factor: 5.191

2.  Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity.

Authors:  Jacqueline A Pettersen; Gareth Jones; Catherine Worthington; Hartmut B Krentz; Oliver T Keppler; Ahmet Hoke; M John Gill; Christopher Power
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

3.  Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection.

Authors:  Leslie A Lenert; Martin Feddersen; Ann Sturley; Daniel Lee
Journal:  Am J Med       Date:  2002-08-15       Impact factor: 4.965

4.  Short communication: Apoptosis pathways in HIV-1-infected patients before and after highly active antiretroviral therapy: relevance to immune recovery.

Authors:  David L Pitrak; Richard M Novak; Randee Estes; Jean Tschampa; Christina D Abaya; Jeffrey Martinson; Kirsten Bradley; Allan R Tenorio; Alan L Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-11       Impact factor: 2.205

Review 5.  Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

Authors:  T N Kakuda
Journal:  Clin Ther       Date:  2000-06       Impact factor: 3.393

6.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

Review 7.  HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo.

Authors:  Stacey R Vlahakis; Steffany A L Bennett; Shawn N Whitehead; Andrew D Badley
Journal:  Apoptosis       Date:  2007-05       Impact factor: 4.677

Review 8.  Safety and Tolerability: Current Challenges to Antiretroviral Therapy for the Long-Term Management of HIV Infection.

Authors:  Jesús Troya; José Bascuñana
Journal:  AIDS Rev       Date:  2016 Jul-Sep       Impact factor: 2.500

9.  Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006.

Authors:  K Smyth; J S Affandi; J C McArthur; C Bowtell-Harris; A M Mijch; K Watson; K Costello; I J Woolley; P Price; S L Wesselingh; C L Cherry
Journal:  HIV Med       Date:  2007-09       Impact factor: 3.180

10.  Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

Authors:  Richard H Haubrich; Sharon A Riddler; A Gregory DiRienzo; Lauren Komarow; William G Powderly; Karin Klingman; Kevin W Garren; David L Butcher; James F Rooney; David W Haas; John W Mellors; Diane V Havlir
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

View more
  2 in total

1.  Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection.

Authors:  Nicholas Rhoades; Norma Mendoza; Allen Jankeel; Suhas Sureshchandra; Alexander D Alvarez; Brianna Doratt; Omeid Heidari; Rod Hagan; Brandon Brown; Steven Scheibel; Theodore Marbley; Jeff Taylor; Ilhem Messaoudi
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

2.  Minimum redundancy maximal relevance gene selection of apoptosis pathway genes in peripheral blood mononuclear cells of HIV-infected patients with antiretroviral therapy-associated mitochondrial toxicity.

Authors:  Eliezer Bose; Elijah Paintsil; Musie Ghebremichael
Journal:  BMC Med Genomics       Date:  2021-12-01       Impact factor: 3.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.